Testing 1,2,3

I've been away this week and have not checked in because I have been at the hospital getting poked and prodded and tested. Besides all the test and blood I have to give monthly, I get a full check and multiple test annually. It takes multiple days so I have been staying at a hotel. I am very tired and glad to be home.

I know this is short and doesn't say much, but this chronic illness grinds you down slowly. It whittles away at who you are. The only victories is getting up every day fighting to keep your strength and to keep keep the Encephalopathy at bay as much as possible.

Forever Changed: Random Reflections

Forever Changed: Random Reflections

100.  That’s how many posts I’ve written on here.  100!  Y’all don’t know me well enough to know how huge that is.  I almost never stick to anything that I start.  When I first started this blog, I never would have imagined how therapeutic it would prove to be.  I just wanted somewhere to write my updates for my family and somewhere to put my random thoughts.  You see, when you have chronic…

View On WordPress

Top 10 Most Deadly Diseases Worldwide

Top 10 Most Deadly Diseases Worldwide

Diseases are referred to as conditions where body parts function abnormally. It is a medical condition, which is usually linked to some kind of signs and symptoms. Some diseases are dangerous and can cause death while some are easily curable. Millions of people die around the world from different types of deadly diseases throughout the year. We should always take precautions to prevent ourselves…

View On WordPress

Women, alcohol, and COVID-19. @HarvardHealth

Women, alcohol, and COVID-19. @HarvardHealth

Harvard Health@HarvardHealth·Apr 7Excessive alcohol use is a common response to coping with stress, but the physical, mental, and emotional impacts of the #COVID19 pandemic have had a disproportionate effect on women: https://bit.ly/3fNWJlN #HarvardHealth

View On WordPress

One Life: A PBC Update

One Life: A PBC Update

After much testing, I finally had a follow-up with my gastroenterologist, who sees me for my PBC diagnosis.  Previously, she had acted like I did not have PBC and we argued extensively over it.  Ultimately, she made me do an unnecessary liver biopsy just so that I could prove to her that I am not a hypochondriac, and that I do, in fact, have this rare autoimmune liver disease that will eventually…

View On WordPress

#health #benefits of #carrot : it #helps in : #skincare #skinhealth #shinyskin #constipation #digestion #liverdetox #liverhealth #detox #heartattack #cholesterol #heartdisease #bloodthinners #brainhealth #brainstroke #ischemicstroke #dentalcare #teethcare #gumdisease #bloodpressure #hypertension #bloodclot #cancer #cancerawareness #cancersucks #cancersurvivor

I don't usually put my pictures all over the web but I think this one is safe enough. Thought I would show you how I spent a couple of days this week. I'm a little tired now. Note the pink cap. Fashion first, always.

Liver Diseases Therapeutics Market to Reach US$ 24,921.3 Million by 2027

Symptoms of liver disease include swelling of the abdomen and legs, bruising easily, changes in the color of stool and urine, and jaundice, or yellowing of the skin and eyes. Peroxisome Proliferator-activated Receptors (PPAR)-alpha agonist, ACE Inhibitors, Hepatotropic Drug, and others therapies are used for the treatment of liver diseases.

The global liver diseases therapeutics market is estimated to account for US$ 12,851.3 Mn in terms of value in 2020 and is expected to reach US$ 24,921.3 Mn by the end of 2027.

Global Liver Diseases Therapeutics Market: Drivers

Increasing approval and launch of novel therapies for the treatment of liver diseases is expected to propel growth of the global liver diseases therapeutics market over the forecast period. For instance, in March 2020, the U.S. Food and Drug Administration (FDA) approved a combination of the checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) for people with advanced hepatocellular carcinoma, a liver cancer.

Global Liver Diseases Therapeutics Market: Opportunities

R&D of novel therapies is expected to offer lucrative growth opportunities for players in the global liver diseases therapeutics market. For instance, in April 2020, researchers from Osaka City University Graduate School of Medicine, Japan, in the Journal of Hepatology, reported novel highlights in the pathophysiology of human nonalcoholic steatohepatitis with fibrosis and suggested a new approach for the treatment of the condition using cytoglobin inducer.

Global Liver Diseases Therapeutics Market: Restraints

Absence of effective therapeutics for the treatment of hepatocellular carcinoma is expected to hinder growth of the market. Treatment of liver cancer is largely limited to chemotherapy or surgical removal. However, liver naturally resists to damage by chemicals, which makes chemotherapy a less effective approach.

Key Takeaways:

The global liver diseases therapeutics market was valued at US$ 11,854.7 Mn in 2019 and is forecast to reach a value of US$ 24,921.3 Mn by 2027 at a CAGR of 9.7% between 2020 and 2027. Increasing prevalence of diseases such as hepatitis and liver cancer is expected to support growth of the market over the forecast period.

Antiviral drugs segment held dominant position in the global liver diseases therapeutics market in 2019, accounting for 32.7% share in terms of value, followed by vaccines and chemotherapy drugs, respectively. Antiviral drugs are used in the treatment of hepatitis, and new drug launches are expected to support growth of this segment.

Hospital Pharmacies segment held dominant position in the global liver diseases therapeutics market in 2019, accounting for 41.3% share in terms of value, followed by retail pharmacies and online pharmacies, respectively.

Market Trends

The U.S. is witnessing increase in cases of hepatitis C virus (HCV) infection. For instance, in April 2020, the Centers for Disease Control and Prevention stated the rate of new HCV infections increased by about 300% among people ages 20 to 29 and by about 400% among those ages 30 to 39.

The market is witnessing R&D in liver fibrosis. For instance, in March 2020, Theratechnologies Inc., a commercial-stage biopharmaceutical company, announced a data presentation that demonstrated relation of visceral fat in the prediction of liver fibrosis and liver fibrosis progression.

Global Liver Diseases Therapeutics Market: Competitive Landscape

Major players operating in the global liver diseases therapeutics market include, Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, Glaxosmithkline Plc, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A, Pfizer Inc., Takeda Pharmaceutical, Valeant Pharmaceuticals, Watson Pharmaceuticals, Inc., Theratechnologies Inc., Alnylam Pharmaceuticals, Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo International, Provectus Biopharmaceuticals Inc., and MAX BioPharma, Inc.

Global Liver Diseases Therapeutics Market: Key Developments

April 2020: Provectus Biopharmaceuticals Inc.’s data from its clinical trial of autolytic cancer immunotherapy PV-10 (rose bengal disodium) as a single-agent and in combination with immune checkpoint blockade for the treatment of primary or metastatic tumors of the liver was uploaded to the SIR 2020 ePoster Gallery of the canceled Society of Interventional Radiology 2020 Annual Scientific Meeting.

March 2020: MAX BioPharma, Inc. announced, through a published article, the efficacy of its anti-tumorigenic oxysterol lead compound, Oxy210, in the treatment of liver fibrosis

Segmentation

By Therapy Type

By Distribution Channel

By Region

Anti-Rejection Drugs/Immunosuppressant’s

Chemotherapy Drugs

Targeted therapy

Vaccines

Anti-Viral Drugs

Immunoglobulins

Corticosteroids

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

CMI Services:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

About Us-

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Contact Us:

Mr. Shah

Coherent Market Insights Pvt Ltd, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

sales@coherentmarketinsights.com

Related links:

CMI Industries

CMI Press Release

CMI Resource Centre

Covid 19 Impact Tracker

#health #benefits of #capsicum : #cancer #cancerdiet #cancerawareness #cancersurvivor #cancersucks #chronsdisease #hearthealth #heart #cholesterol #heartattack #autoimmunedisease #gout #rheumatoidarthritis #lupus #jaundice #virus #viralinfection #immunity #immunebooster #yellowfever #manopause #menstrualhealth #hormonebalance #skincare #shinyskin #youngliving #intestinalhealth

Swing and a Miss

Sunday at 5am my phone rings. It's the transplant nurse. Get there now.

Emotions run the whole gambit. The day is full of tests, labs, prep and IV. I'm told I will go into surgery at 5:30pm. My wife is trying to not let me see her cry.

At 4pm we get the news. The liver is not viable, no surgery for me. Emotions flip flop. I had to harden myself, and say let's get it done. For me it was like armoring up, and getting your mind right. Then nothing. I had not eaten for a day, not had anything to drink. All day I would have mugged an old lady for a cup of ice chips.

So now, I have to release the adrenaline. The weakness and shakes come from holding on so long.

Sweet ice water, with crushed ice. I don't ask for much. Two and a half hour ride home. I let my wife drive because I don't have much energy left. Home by 7pm. Some scrambled eggs, cheese, mushrooms and a little left over steak. Off to bed by 8:30. Sleep is fit full.

It was a good practice run, but it was not meant to be.

I have faith that whatever happens was meant to be. If I get a transplant or if I die. It is my family that will suffer the most. I would spare them that anguish, but it's not up to me.

Maybe next time.

Hepatitis B - Causes and Ayurvedic Treatment

Diageo use Maya Jama. #smirnoffseltzer

smirnoffeuropeVerifiedHere’s @mayajama enjoying the results of her Smirnoff Seltzer Can Do Spirit Challenge.We don’t want to leave you hanging, so as part of this challenge, we are giving 5 lucky followers the opportunity to win their own Smirnoff Seltzer Movie Night Hamper 🍿All you have to do is tell us your favourite film in the comments below!Entrants must be 18+ to enter. UK residents only.…

View On WordPress

The Liver Clinic India - Offline & Online Consultations

The Liver Clinic India – Offline & Online Consultations

Patients from different parts of the world come for ethical opinion The Liver Clinic, Delhi – For all your issues related to Liver Disease and Liver Transplantation. Ethical Opinion is our Culture for which patients come from different parts of the world both Online and Offline. Appointment Helpline +91 9266782222

View On WordPress

#health #benefits of #cherry : #kidneydisease #renaldiet #renal #kidneyproblems #liverhealth #liverdetox #toxinfree #bloodpurifier #heartattack #heart #heartdisease #antiaging #longevity #cancer #cancerdiet #cancerawareness #pain #memory #periodpain #dementia #mentalhealth #menstrualhealth #mood #immunity #immunebooster #infection #viralinfection

Permanent Cure of Fatty Liver in Ayurveda

Liver Disease Is On The Rise Due To Pandemic Alcohol Abuse

Liver Disease Is On The Rise Due To Pandemic Alcohol Abuse #LiverDisease #Liver #PandemicAlcoholAbuse #Pandemic #AlcoholAbuse #Alcohol #health #covid #covid19 #coronavirus #Disease

Currently, COVID-19 has stopped the world. It is also creating negative results in every sector of life. Throughout the globe, people have been facing various problems due to it. Therefore, this article would tell you another important issue that arose due to the pandemic. The problem is the rapidly rising cases of liver disease. Doctors and frontline workers at the hospitals have shown huge…

View On WordPress

Nonalcoholic fatty liver disease (NAFLD)

Nonalcoholic fatty liver disease (NAFLD) #NAFLD #fattyliverdisease #liverdisease #obesity #overweight

Nonalcoholic fatty liver disease (NAFLD) What is Nonalcoholic fatty liver disease (NAFLD)? Non-alcoholic fatty liver disease (NAFLD) is a liver disease. In this condition, there is a fat accumulation in the liver that is not due to drinking too much alcohol. NAFLD is seen in people who are overweight or obese. What are the causes and risk factors of nonalcoholic fatty liver disease…

View On WordPress